- Lilly Diabetes expands collaboration with Disney Publishing Worldwide globally.
- New educational resources will be available soon for families of children with type 1 diabetes.
While the public seized on Mylan's price increases for EpiPens, the story of a common drug industry practice - increasing prices ahead of generics entering the market - got lost.
Shares of biotech micro-cap Cyclacel Pharmaceuticals have doubled in price in the past 10 days. Call it the Lloyd Christmas effect.